Quanterix Corporation (QTRX)
USD 6.21
(-7.59%)
USD 6.21
(-7.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 118.1 Million USD | -0.85% |
| 2022 | 118.59 Million USD | -1.43% |
| 2021 | 120.31 Million USD | 50.83% |
| 2020 | 79.76 Million USD | 16.56% |
| 2019 | 68.43 Million USD | 39.47% |
| 2018 | 49.06 Million USD | 36.33% |
| 2017 | 35.99 Million USD | 22.18% |
| 2016 | 29.45 Million USD | 45.56% |
| 2015 | 20.23 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 33.16 Million USD | -2.02% |
| 2024 Q1 | 33.59 Million USD | 7.79% |
| 2023 Q1 | 26.15 Million USD | 3.27% |
| 2023 Q2 | 28.54 Million USD | 9.12% |
| 2023 FY | 117.58 Million USD | -0.85% |
| 2023 Q3 | 31.05 Million USD | 8.8% |
| 2023 Q4 | 31.16 Million USD | 0.35% |
| 2022 Q2 | 33.59 Million USD | 2.59% |
| 2022 Q3 | 26.31 Million USD | -21.67% |
| 2022 FY | 118.59 Million USD | -1.43% |
| 2022 Q1 | 32.74 Million USD | -9.43% |
| 2022 Q4 | 25.32 Million USD | -3.75% |
| 2021 Q4 | 36.15 Million USD | 22.7% |
| 2021 Q1 | 23.84 Million USD | -4.55% |
| 2021 Q2 | 26.6 Million USD | 11.54% |
| 2021 FY | 120.31 Million USD | 50.83% |
| 2021 Q3 | 29.46 Million USD | 10.78% |
| 2020 Q4 | 24.98 Million USD | 47.84% |
| 2020 FY | 79.76 Million USD | 16.56% |
| 2020 Q3 | 16.89 Million USD | -2.96% |
| 2020 Q2 | 17.41 Million USD | -6.08% |
| 2020 Q1 | 18.54 Million USD | 1.04% |
| 2019 FY | 68.43 Million USD | 39.47% |
| 2019 Q3 | 17.27 Million USD | -0.97% |
| 2019 Q2 | 17.44 Million USD | 13.54% |
| 2019 Q4 | 18.35 Million USD | 6.22% |
| 2019 Q1 | 15.36 Million USD | 8.27% |
| 2018 Q3 | 13.25 Million USD | 17.48% |
| 2018 Q4 | 14.19 Million USD | 7.05% |
| 2018 FY | 49.06 Million USD | 36.33% |
| 2018 Q1 | 7.82 Million USD | -21.51% |
| 2018 Q2 | 11.28 Million USD | 44.15% |
| 2017 Q4 | 9.97 Million USD | 11.41% |
| 2017 Q1 | 8.41 Million USD | -19.08% |
| 2017 Q2 | 8.65 Million USD | 2.78% |
| 2017 FY | 35.99 Million USD | 22.18% |
| 2017 Q3 | 8.95 Million USD | 3.49% |
| 2016 Q3 | 6.51 Million USD | -0.76% |
| 2016 Q2 | 6.56 Million USD | 10.82% |
| 2016 Q1 | 5.92 Million USD | 0.0% |
| 2016 FY | 29.45 Million USD | 45.56% |
| 2016 Q4 | 10.4 Million USD | 59.62% |
| 2015 FY | 20.23 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -952.21% |
| Cerus Corporation | 143.15 Million USD | 17.502% |
| OrthoPediatrics Corp. | 137.01 Million USD | 13.808% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -939.533% |
| Talis Biomedical Corporation | 67.18 Million USD | -75.781% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -373.423% |
| Inogen, Inc. | 236.08 Million USD | 49.976% |
| Spectral AI, Inc. | 20.86 Million USD | -466.047% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -110.904% |
| CVRx, Inc. | 76.14 Million USD | -55.105% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -3247.509% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -845.632% |
| Orthofix Medical Inc. | 667.42 Million USD | 82.305% |
| Venus Concept Inc. | 80.47 Million USD | -46.752% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -108.738% |
| Bioventus Inc. | 409.91 Million USD | 71.189% |
| BrainsWay Ltd. | 28.01 Million USD | -321.515% |
| Envoy Medical, Inc. | 17.89 Million USD | -559.85% |
| electroCore, Inc. | 32.03 Million USD | -268.705% |
| IceCure Medical Ltd | 16.87 Million USD | -599.81% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -178.328% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -569.766% |
| MaxCyte, Inc. | 84.84 Million USD | -39.195% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -851.516% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1942.773% |
| PAVmed Inc | 64.82 Million USD | -82.177% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -131.215% |
| RxSight, Inc. | 103.85 Million USD | -13.722% |
| Sight Sciences, Inc. | 126.44 Million USD | 6.603% |
| SI-BONE, Inc. | 156.35 Million USD | 24.465% |
| TELA Bio, Inc. | 84.18 Million USD | -40.283% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -68.579% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 41.927% |
| LivaNova PLC | 843.54 Million USD | 86.0% |
| 908 Devices Inc. | 68.08 Million USD | -73.472% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 75.579% |
| Nemaura Medical Inc. | 7.13 Million USD | -1554.339% |
| NeuroPace, Inc. | 75.29 Million USD | -56.848% |
| LENSAR, Inc. | 33.33 Million USD | -254.272% |
| Apyx Medical Corporation | 51.01 Million USD | -131.487% |
| Cutera, Inc. | 197.72 Million USD | 40.27% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -376.575% |
| BioSig Technologies, Inc. | 28.53 Million USD | -313.95% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 38.321% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -227.51% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 85.88% |
| Axonics, Inc. | 270.2 Million USD | 56.292% |
| Outset Medical, Inc. | 198.77 Million USD | 40.585% |
| IRIDEX Corporation | 31.81 Million USD | -271.22% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 34.469% |
| IRadimed Corporation | 30.12 Million USD | -292.062% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1284.201% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1403.828% |
| Telesis Bio, Inc. | 63.48 Million USD | -86.016% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -19.956% |
| Varex Imaging Corporation | 224.8 Million USD | 47.464% |
| Quipt Home Medical Corp. | 148.66 Million USD | 20.561% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -907.421% |
| Pulmonx Corporation | 112.68 Million USD | -4.804% |
| Dynatronics Corporation | 9.9 Million USD | -1091.963% |
| Modular Medical, Inc. | 17.52 Million USD | -573.741% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -485.03% |
| Semler Scientific, Inc. | 38.94 Million USD | -203.256% |
| InMode Ltd. | 215.68 Million USD | 45.243% |
| Bruker Corporation | 1.07 Billion USD | 89.028% |
| Cytosorbents Corporation | 48.33 Million USD | -144.327% |
| DexCom, Inc. | 1.69 Billion USD | 93.017% |
| Align Technology, Inc. | 2.07 Billion USD | 94.313% |
| Viveve Medical, Inc. | 22.17 Million USD | -432.63% |
| ZimVie Inc. | 275.12 Million USD | 57.074% |
| Movano Inc. | 29.69 Million USD | -297.777% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 13.966% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1942.773% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -3247.509% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 80.347% |
| Profound Medical Corp. | 33.6 Million USD | -251.455% |
| Insulet Corporation | 939.9 Million USD | 87.435% |
| enVVeno Medical Corporation | 25.23 Million USD | -367.945% |
| Surmodics, Inc. | 98.69 Million USD | -19.659% |
| iCAD, Inc. | 22.22 Million USD | -431.384% |
| Nuwellis, Inc. | 22.61 Million USD | -422.266% |
| Biotricity, Inc. | 17.18 Million USD | -587.245% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 73.514% |
| Aethlon Medical, Inc. | 12.27 Million USD | -861.921% |
| InspireMD, Inc. | 22.95 Million USD | -414.597% |
| PAVmed Inc. | 64.82 Million USD | -82.177% |
| BIOLASE, Inc. | 34.66 Million USD | -240.729% |
| Beyond Air, Inc. | 61.7 Million USD | -91.41% |
| FONAR Corporation | 28.6 Million USD | -312.869% |
| AxoGen, Inc. | 149.33 Million USD | 20.917% |
| Vivani Medical, Inc. | 26.96 Million USD | -337.975% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 33.311% |
| Inari Medical, Inc. | 448.59 Million USD | 73.673% |
| UFP Technologies, Inc. | 58.08 Million USD | -103.309% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -2296.705% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -1769.177% |
| Tenon Medical, Inc. | 16.96 Million USD | -596.016% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1497.457% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -167.783% |
| AdaptHealth Corp. | 1.07 Billion USD | 89.044% |
| Sintx Technologies, Inc. | 15.2 Million USD | -676.923% |
| NanoVibronix, Inc. | 4.97 Million USD | -2274.824% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -907.421% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -717.754% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 69.924% |
| TransMedics Group, Inc. | 182.82 Million USD | 35.401% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -320.809% |
| NeuroMetrix, Inc. | 11.09 Million USD | -964.066% |
| Hyperfine, Inc. | 52.87 Million USD | -123.37% |
| Establishment Labs Holdings Inc. | 172 Million USD | 31.338% |
| Biomerica, Inc. | 6.97 Million USD | -1592.462% |
| Bone Biologics Corporation | 9.42 Million USD | -1152.611% |
| AVITA Medical, Inc. | 80.77 Million USD | -46.201% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1045.355% |
| Silk Road Medical, Inc | 186.35 Million USD | 36.627% |